SEARCH

SEARCH BY CITATION

References

  • 1
    Willett WC. Nutritional Epidemiology, 2nd edn. New York, NY: Oxford University Press; 1998.
  • 2
    Xun P, Liu K, Morris JS, Daviglus ML, He K. Longitudinal association between toenail selenium levels and measures of subclinical atherosclerosis: the CARDIA trace element study. Atherosclerosis. 2010;210:6627.
  • 3
    Xun P, Liu K, Morris JS, Daviglus ML, Stevens J, Jacobs DR et al. Associations of toenail selenium levels with inflammatory biomarkers of fibrinogen, high-sensitivity C-reactive protein, and interleukin-6: the CARDIA Trace Element Study. Am J Epidemiol 2010;171:793800.
  • 4
    Tosi A, Piraccini B. Biology of nail, 5th edn. New York: McGraw-Hill; 1999.
  • 5
    Hulka BS, Wilcosky TC, Griffith JD. Biological markers in epidemiology. New York, NY: Oxford University Press; 1990.
  • 6
    Edwards LF, Schott RG. The daily rate of growth of toe nails. Ohio J Sci 1937;XXXVII:918.
  • 7
    Yaemsiri S, Hou N, Slining MM, He K. Growth rate of human fingernails and toenails in healthy American young adults. J Eur Acad Dermatol Venereol 2009;24:4203.
  • 8
    Longnecker MP, Stampfer MJ, Morris JS, Spate V, Baskett C, Mason M et al. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 1993;57:40813.
  • 9
    Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ et al. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 1993;2:4937.
  • 10
    Krogh V, Pala V, Vinceti M, Berrino F, Ganzi A, Micheli A et al. Toenail selenium as biomarker: reproducibility over a one-year period and factors influencing reproducibility. J Trace Elem Med Biol 2003;17(Suppl. 1):316.
  • 11
    Ovaskainen ML, Virtamo J, Alfthan G, Haukka J, Pietinen P, Taylor PR et al. Toenail selenium as an indicator of selenium intake among middle-aged men in an area with low soil selenium. Am J Clin Nutr 1993;57:6625.
  • 12
    Hunter DJ, Morris JS, Chute CG, Kushner E, Colditz GA, Stampfer MJ et al. Predictors of selenium concentration in human toenails. Am J Epidemiol 1990;132:11422.
  • 13
    Van Den Brandt PA, Goldbohm RA, Van‘t Veer P, Bode P, Dorant E, Hermus RJ et al. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res 1993;53:48605.
  • 14
    Hartman TJ, Taylor PR, Alfthan G, Fagerstrom R, Virtamo J, Mark SD et al. Toenail selenium concentration and lung cancer in male smokers (Finland). Cancer Causes Control 2002;13:9238.
  • 15
    Garland M, Morris JS, Stampfer MJ, Colditz GA, Spate VL, Baskett CK et al. Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 1995;87:497505.
  • 16
    Zhuo H, Smith AH, Steinmaus C. Selenium and lung cancer: a quantitative analysis of heterogeneity in the current epidemiological literature. Cancer Epidemiol Biomarkers Prev 2004;13:7718.
  • 17
    Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:121924.
  • 18
    Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 2000;92:201823.
  • 19
    Ghadirian P, Maisonneuve P, Perret C, Kennedy G, Boyle P, Krewski D et al. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev 2000;24:30513.
  • 20
    Van Den Brandt PA, Zeegers MP, Bode P, Goldbohm RA. Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2003;12:86671.
  • 21
    Allen NE, Morris JS, Ngwenyama RA, Key TJ. A case--control study of selenium in nails and prostate cancer risk in British men. Br J Cancer 2004;90:13926.
  • 22
    Lipsky K, Zigeuner R, Zischka M, Schips L, Pummer K, Rehak P et al. Selenium levels of patients with newly diagnosed prostate cancer compared with control group. Urology 2004;63:9126.
  • 23
    Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer 2006;42:246371.
  • 24
    Zeegers MP, Goldbohm RA, Bode P, Van Den Brandt PA. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 2002;11:12927.
  • 25
    Michaud DS, Hartman TJ, Taylor PR, Pietinen P, Alfthan G, Virtamo J et al. No Association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:15056.
  • 26
    Sakoda LC, Graubard BI, Evans AA, London WT, Lin WY, Shen FM et al. Toenail selenium and risk of hepatocellular carcinoma mortality in Haimen City, China. Int J Cancer 2005;115:61824.
  • 27
    Rogers MA, Thomas DB, Davis S, Vaughan TL, Nevissi AE. A case-control study of element levels and cancer of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 1993;2:30512.
  • 28
    Vinceti M, Venturelli M, Sighinolfi C, Trerotoli P, Bonvicini F, Ferrari A et al. Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ 2007;373:7781.
  • 29
    Campos FI, Koriyama C, Akiba S, Carrasquilla G, Serra M, Carrascal E et al. Toenail zinc level and gastric cancer risk in Cali, Colombia. J Cancer Res Clin Oncol 2008;134:16978.
  • 30
    Kok FJ, Hofman A, Witteman JC, De Bruijn AM, Kruyssen DH, De Bruin M et al. Decreased selenium levels in acute myocardial infarction. JAMA 1989;261:11614.
  • 31
    Guallar E, Sanz-Gallardo MI, Van’t Veer P, Bode P, Aro A, Gomez-Aracena J et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002;347:174754.
  • 32
    Rajpathak S, Rimm EB, Li T, Morris JS, Stampfer MJ, Willett WC et al. Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 2004;27:22116.
  • 33
    Guallar E, Van’t Veer P, Bode P, Riemersma RA, Gomez-Aracena J, Kark JD et al. Low toenail chromium and increased risk of myocardial infarction. Am J Epidemiol 2005;162:15764.
  • 34
    Gomez-Aracena J, Martin-Moreno JM, Riemersma RA, Bode P, Gutierrez-Bedmar M, Gorgojo L et al. Association between toenail scandium levels and risk of acute myocardial infarction in European men: the EURAMIC and Heavy Metals Study. Toxicol Ind Health 2002;18:35360.
  • 35
    Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol 2000;152:8490.
  • 36
    Karagas MR, Morris JS, Weiss JE, Spate V, Baskett C, Greenberg ER. Toenail samples as an indicator of drinking water arsenic exposure. Cancer Epidemiol Biomarkers Prev 1996;5:84952.
  • 37
    Karagas MR, Le CX, Morris S, Blum J, Lu X, Spate V et al. Markers of low level arsenic exposure for evaluating human cancer risks in a US population. Int J Occup Med Environ Health 2001;14:1715.
  • 38
    Chen KL, Amarasiriwardena CJ, Christiani DC. Determination of total arsenic concentrations in nails by inductively coupled plasma mass spectrometry. Biol Trace Elem Res 1999;67:10925.
  • 39
    Lin TH, Huang YL, Wang MY. Arsenic species in drinking water, hair, fingernails, and urine of patients with blackfoot disease. J Toxicol Environ Health A 1998;53:8593.
  • 40
    Longnecker MP, Stram DO, Taylor PR, Levander OA, Howe M, Veillon C et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 1996;7:38490.
  • 41
    Tang YR, Zhang SQ, Xiong Y, Zhao Y, Fu H, Zhang HP et al. Studies of five microelement contents in human serum, hair, and fingernails correlated with aged hypertension and coronary heart disease. Biol Trace Elem Res 2003;92:97104.
  • 42
    Agency for toxic substances and disease registry. Toxicological Profile for Arsenic. Atlanta, GA: U.S. Department of Health & Human Services; 1993.
  • 43
    Ilhan A, Ozerol E, Gulec M, Isik B, Ilhan N, Akyol O. The comparison of nail and serum trace elements in patients with epilepsy and healthy subjects. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:99104.
  • 44
    Jurado C, Kintz P, Menendez M, Repetto M. Influence of the cosmetic treatment of hair on drug testing. Int J Legal Med 1997;110:15963.
  • 45
    Lazar P. Editorial: hair analysis: what does it tell us? JAMA 1974;229:19089.
  • 46
    Hambidge KM. Hair analyses: worthless for vitamins, limited for minerals. Am J Clin Nutr 1982;36:9439.
  • 47
    Klevay LM, Bistrian BR, Fleming CR, Neumann CG. Hair analysis in clinical and experimental medicine. Am J Clin Nutr 1987;46:2336.
  • 48
    Barrett S. Commercial hair analysis. Science or scam? JAMA 1985;254:10415.
  • 49
    Alfassi ZB. Chemical Analysis by Nuclear Methods. New York, NY: John Wiley and Sons; 1994.
  • 50
    Nelms S. Inductively Coupled Plasma Mass Spectrometry Handbook. Oxford, UK: Blackwell Publishing; 2005.